HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Volume 20, No. 8, August 2016 – Novel Technologies for Antibody Drug Discovery in Japan       » Global Experts Convene to Discuss China's Plan for Diabetes Prevention and Rehabilitation in 2016       » Butterflies Offer Climate Scientists Ecological Insights       » Thermal Stability of Camelid Single Domain VHH Antibody       » That Gut Feeling: How A Healthy Digestive System Has Everything To Do With It       » World Heart Day - At the Heart of Health      
INSIDE INDUSTRY
Agilent Technologies’ and PREMIER Biosoft's platforms work together to advance lipidomics research
Agilent Technologies Inc. and PREMIER Biosoft announced that they will each support the combined use of their respective technologies to help clinical researchers advance lipidomics research. By integrating complementary technologies, researchers can seamlessly generate and process data, then map complex lipidomic networks to learn more about lipid metabolism associated with disease.

The power of Agilent's industry-leading time-of-flight and quadrupole time-of-flight mass spectrometers and Pathway Architect software combined with Premier Biosoft's SimLipid 3.3 identification and quantification software enables researchers to overcome many of the obstacles inherent in lipid identification and analysis. This will give them a distinct advantage in their efforts to map the lipid pathways associated with metabolic disease.

“Just as challenging as mapping and sequencing the human genome is identifying and sequencing the thousands of lipid species involved in human metabolism,” said Dr. Daniel B. Kassel, Agilent's senior director of LC/MS global marketing. “By utilizing this combined network of technologies, researchers can be confident in the analytical strength they have come to expect from Agilent and from the advanced lipid identification capabilities provided in PREMIER Biosoft's SimLipid software.”

“By connecting these complementary technologies, researchers can maximize the analytical capabilities of Agilent's high-end MS instrumentation and software with our high-throughput MS and MS/MS data analysis tools,” said Arun Apte, Chief Executive Officer at PREMIER Biosoft. “Our SimLipid software supports data from Agilent's well-known MassHunter, Mass Profiler Professional and Pathway Architect software programs, creating an integrated workflow for the accurate and efficient identification and contextualization of lipids on metabolic pathways.”

Click here for the complete issue.

NEWS CRUNCH  
news CPhI's Pre-Connect Congress outlines current trends in pharma
news World Population Day 2016
news NUS Student Clinches Top Prize at National Smart Mapping Competition with Cutting-Edge Food Security Solution
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2016
January:
Guest Editorial - Biotechnology In Korea
February:
Guest Editorial - Biomedical Research Governance
March:
Guest Editorial - Life-Saving Opportunities: A Guide to Regenerative Medicine
April:
Leading-Edge ONCOLOGY
May:
Healthcare Systems & Policies in Asia
June:
Medical Devices & Healthcare Technology
July:
Water Technology and Management
August:
Novel Technologies for Antibody Drug Discovery in Japan
September:
Infectious Diseases
October:
Medical Tourism
November:
Big Data in Healthcare
December:
Evidence-based TCM
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com or Mr Edward
Copyright© 2016 World Scientific Publishing Co Pte Ltd  •  Privacy Policy